After years of letting this monster run, Jason just pulled the trigger on a rare trim (locking in 1,400% profits). In short, the valuation got extreme. This isn’t panic selling — it’s smart risk management — and a chance to turn one big win into multiple new income streams.
Read MoreJust about everything in finance follows trends. And when the trend is in your favor, it’s like sailing with the wind at your back. We’re living in one of those moments right now.
Read MoreA portfolio doesn’t need to be complicated or regularly updated to be productive. In fact, less tinkering and tweaking may yield better results.
Read MoreOur target potential upside is 20%-38% in the next 3-6 months.
Read MoreHere are today’s upgrades and downgrades: Nio, Ambev, Zscaler, NetApp, Autodesk, Inspire Medical, Carlsberg and more.
Read MoreWith a market-smashing yield, more than 50 consecutive years of dividend increases, and the potential that shares are 10% undervalued, this Dividend King is worthy of consideration for income-seeking dividend growth investors.
Read MoreAs I continued to study the market early in my career, I learned something stunning…
Read MoreThese funds should be good choices since they provide low-cost and uncomplicated equity funds that can help investors meet their financial goals.
Read MoreThese names look poised to make a move in the coming days: Alphabet, Hormel Foods, Lennar and more.
Read MoreHere are today’s upgrades and downgrades: Merck, Cummins, Baidu, Carvana, Tractor Supply, Jazz Pharmaceuticals and more.
Read MoreWhat a time to be a contrarian! The current setup has presented some VERY attractive deals in 8%-paying closed-end funds (CEFs), many of which have gone on sale in the last few weeks.
Read MoreFor most investors, the Oracle of Omaha’s lead is still well worth following.
Read More